GSTM1 and chronic kidney disease: The National Kidney Foundation-Kidney Disease Outcomes Quality Initiative (NKF-KDOQI) guidelines (2000) recommended that the selected Hb targets should generally be maintained in the range of 11.0 to 12.0 g/dL in patients with CKD, whether or not they were receiving dialysis [6].